Dietary Fat Reduction Improves Long-Term Survival in ER-negative Breast Cancers
Reducing dietary fat intake appears to improve survival rates among women with certain types of breast cancer.
Reducing dietary fat intake appears to improve survival rates among women with certain types of breast cancer.
Targeting the proteasome might help prevent breast tumor resistance to endocrine therapy.
Extending duration of dual anti-HER2 therapy without chemotherapy did not significantly improve molecular response in HER2-positive breast tumors.
Adding everolimus to paclitaxel, trastuzumab does not significantly prolong progression-free survival (PFS) in breast cancer.
Ultrasound breast screenings for women with dense breast tissue improves cancer detection.
The Oncotype DX DCIS Score accurately predicts recurrence risk for patients treated with breast-conserving surgery (BCS).
Accelerated partial breast irradiation (APBI) using intensity-modulation radiotherapy (IMRT) does not reduce local breast cancer recurrence.
Adding ovarian function suppression (OFS) is associated with several patient-reported endocrine symptoms and impacts sexual functioning.
Adding ovarian function suppression (OFS) to adjuvant postsurgical tamoxifen therapy can reduce breast cancer recurrence.
Tamoxifen significantly reduces breast cancer incidence among women at high risk for breast cancer.
Please login or register first to view this content.